Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: A multi-institutional prospective randomized trial of the International Atomic Energy Agency

International Journal of Clinical Oncology

Volumn 12, Issue 3, 2007, Pages 192-198

  Mitsumori, Michihide ^a   Zhi Fan, Zeng ^b   Oliynychenko, Praskovya ^c   Park, Jeong Ho ^d   Choi, Ihl Bohng ^e   Tatsuzaki, Hideo ^f   Tanaka, Yoshiaki ^g   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b SUN YAT SEN UNIVERSITY   (China)

^c Kiev City Oncology Centre   (Ukraine)

^d Maryknoll Hospital   (South Korea)

^e The Catholic University of Korea   (South Korea)

^f NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^g NIHON UNIVERSITY   (Japan)

Author keywords

Hyperthermia; Lung cancer; Radiation therapy; Randomized controlled trial

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TOXICITY; TREATMENT RESPONSE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 34250729555     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0647-5     Document Type: Article

References (17)

1. DM Parkin F Bray J Ferlay 2001 Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 153 156
2. PC Hoffman AM Mauer EE Vokes 2000 Lung cancer Lancet 355 479 485
3. J Bradley R Govindan R Komaki 2003 Lung CA Perez L Brady EC Halperin Principles and practice of radiation oncology Lippincott Williams & Wilkins Philadelphia 1201 1243
4. J Deslauriers 2002 Current surgical treatment of nonsmall cell lung cancer 2001 Eur Respir J Suppl 35 61s 70s
5. DH Johnson 2000 Locally advanced, unresectable non-small cell lung cancer: new treatment strategies Chest 117 123S 126S
6. FB Zimmermann M Bamberg M Molls 2003 Radiation therapy alone in early stage non-small cell lung cancer Semin Surg Oncol 21 91 97
7. AB Miller B Hoogstraten M Staquet 1981 Reporting results of cancer treatment Cancer 47 207 214
8. M Abe M Hiraoka 1985 Localized hyperthermia and radiation in cancer therapy Int J Radiat Biol Relat Stud Phys Chem Med 47 347 359
9. J Overgaard 1989 The current and potential role of hyperthermia in radiotherapy Int J Radiat Oncol Biol Phys 16 535 549
10. P Wust B Hildebrandt G Sreenivasa 2002 Hyperthermia in combined treatment of cancer Lancet Oncol 3 487 497
11. M Hiraoka Y Nishimura Y Nagata 1994 Site-specific phase I, II trials of hyperthermia at Kyoto University Int J Hyperthermia 10 403 410
12. Y Nagata M Hiraoka Y Nishimura 1997 Clinical results of radiofrequency hyperthermia for malignant liver tumors Int J Radiat Oncol Biol Phys 38 359 365
13. RO Dillman J Herndon SL Seagren 1996 Improved survival in stage III non-small-cell lung cancer: 7-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1210 1215
14. T Le Chevalier R Arriagada E Quoix 1994 Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma Lung Cancer 10 Suppl 1 S239 244
15. WT Sause C Scott S Taylor 1995 Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer J Natl Cancer Inst 87 198 205
16. W Curran C Scott C Langer 2003 Long-Term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 94-10 Proc Am Soc Clin Oncol 22 621
17. K Furuse M Fukuoka M Kawahara 1999 Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 2692 2699